AMD (With Persistent or Recurrent Fluid Despite Monthly Intravitreal Anti-VEGF Therapy)
1 clinical trials · Condition
◉ Watch AMD (With Persistent or Recurrent Fluid Despite Monthly Intravitreal Anti-VEGF Therapy)
| Record | Firm | Date |
|---|---|---|
| To Evaluate The Role of Intravitreal Aflibercept Injection (2.0 mg) in the Management of Previously Treated Patients With Exudative AMD (NCT01495221) | Vitreous -Retina- Macula Consultants of New York | 2011-12-01 |
Track AMD (With Persistent or Recurrent Fluid Despite Monthly Intravitreal Anti-VEGF Therapy) automatically
Every clearance here is in the API, with alerts when new ones post.